Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $80.3500 (-9.4%) ($80.0600 - $89.0100) on Wed. Oct. 21, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.58% (three month average) | RSI | 28 | Latest Price | $80.3500(-9.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -4.2% a day on average for past five trading days. | Weekly Trend | LGND declines -5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(51%) IWM(49%) IWC(48%) | Factors Impacting LGND price | LGND will decline at least -1.29% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-14%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.29% (StdDev 2.58%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $97.14 | 5 Day Moving Average | $90.98(-11.68%) | 10 Day Moving Average | $96.13(-16.42%) | 20 Day Moving Average | $97.14(-17.28%) | To recent high | -36.6% | To recent low | 0% | Market Cap | $1.291b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |